IRISanRaf

STOCCHI, FABRIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.780
AS - Asia 5.992
EU - Europa 1.902
Continente sconosciuto - Info sul continente non disponibili 533
SA - Sud America 438
AF - Africa 83
OC - Oceania 25
Totale 19.753
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.801
TR - Turchia 2.074
SG - Singapore 1.777
CN - Cina 1.277
IT - Italia 1.117
CA - Canada 863
BR - Brasile 314
VN - Vietnam 265
DE - Germania 159
HK - Hong Kong 130
BD - Bangladesh 111
EU - Europa 110
GB - Regno Unito 97
IE - Irlanda 78
BE - Belgio 76
IN - India 68
FR - Francia 61
UA - Ucraina 57
PK - Pakistan 47
MX - Messico 44
RU - Federazione Russa 41
IQ - Iraq 38
JP - Giappone 38
NL - Olanda 35
IL - Israele 32
FI - Finlandia 28
AR - Argentina 27
PL - Polonia 27
CO - Colombia 24
ES - Italia 24
VE - Venezuela 21
EC - Ecuador 20
KR - Corea 20
SE - Svezia 20
ZA - Sudafrica 20
PH - Filippine 16
AU - Australia 15
CR - Costa Rica 15
ID - Indonesia 14
GR - Grecia 13
MA - Marocco 13
EG - Egitto 12
TN - Tunisia 12
CL - Cile 11
HN - Honduras 11
LT - Lituania 11
NI - Nicaragua 11
SA - Arabia Saudita 11
DK - Danimarca 10
UZ - Uzbekistan 10
JO - Giordania 9
KE - Kenya 9
MY - Malesia 9
RO - Romania 9
JM - Giamaica 8
NZ - Nuova Zelanda 7
TH - Thailandia 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
SI - Slovenia 6
SV - El Salvador 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
KZ - Kazakistan 5
PE - Perù 5
PS - Palestinian Territory 5
RS - Serbia 5
TW - Taiwan 5
BG - Bulgaria 4
BO - Bolivia 4
PY - Paraguay 4
AT - Austria 3
BB - Barbados 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
NG - Nigeria 3
NP - Nepal 3
PR - Porto Rico 3
AZ - Azerbaigian 2
BH - Bahrain 2
BY - Bielorussia 2
ET - Etiopia 2
GE - Georgia 2
KG - Kirghizistan 2
KW - Kuwait 2
MD - Moldavia 2
OM - Oman 2
PT - Portogallo 2
SN - Senegal 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BT - Bhutan 1
BW - Botswana 1
BZ - Belize 1
CI - Costa d'Avorio 1
DJ - Gibuti 1
GA - Gabon 1
Totale 19.313
Salva come PNG Salva come JPEG
Città #
Kocaeli 1.743
San Mateo 1.283
San Jose 1.135
Ashburn 918
Rome 767
Toronto 765
Council Bluffs 730
Dallas 704
Singapore 496
Santa Clara 425
Chandler 392
Houston 385
Phoenix 376
Wilmington 376
Beijing 338
Princeton 272
Lawrence 249
Fairfield 151
Los Angeles 135
Hong Kong 121
Woodbridge 88
Ho Chi Minh City 86
Seattle 82
Ghent 76
Hanoi 72
Shanghai 70
Guangzhou 61
New York 58
Milan 43
São Paulo 42
Brooklyn 39
Islamabad 35
Shenzhen 34
Cambridge 33
Dublin 32
Munich 32
Chicago 30
Boston 28
Montreal 26
Netanya 25
Frankfurt am Main 22
Tokyo 22
Da Nang 21
Mexico City 21
Warsaw 20
Wuhan 19
Chennai 18
Helsinki 18
Jiaxing 18
Rui'an 18
San Francisco 18
London 17
Abbeville 16
Assago 16
Berlin 16
Boardman 16
Washington 16
Amsterdam 15
Baghdad 15
Stockholm 15
Atlanta 14
Rio de Janeiro 14
Belo Horizonte 12
Denver 12
Manchester 12
The Dalles 12
Dhaka 11
Managua 11
Miami 11
Naples 11
Orem 11
Xi'an 11
Quanzhou 10
San José 10
Ankara 9
Istanbul 9
Johannesburg 9
Palermo 9
Pune 9
Redwood City 9
Wuxi 9
Xuzhou 9
Bologna 8
Charlotte 8
Nairobi 8
Quito 8
Santiago 8
West Jordan 8
Amman 7
Andover 7
Bogotá 7
Buffalo 7
Florence 7
Guayaquil 7
Haiphong 7
Jacksonville 7
Kyiv 7
Medellín 7
Nanjing 7
Poplar 7
Totale 13.476
Salva come PNG Salva come JPEG
Nome #
Conventional Treatment-related Motor Complications: Their Prevention and Treatment 146
A Systems Medicine Clinical Platform for Understanding and Managing Non-Communicable Diseases 142
Morbo di Parkinson: strategie terapeutiche e qualità della vita del malato 119
A pharmacological study of dopaminergic receptors in planaria 104
The pharmacokinetic profile of levodopa administered with and without tolcapone in patients with advanced PD 102
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on qualità of life in Parkinson’s disease 101
L’alimentazione del paziente parkinsoniano 91
Apomorphine and lisuride infusion. A comparative chronic study 88
An open study with reversible MAO-A inhibitors in complicated Parkinson's disease 87
Acute Modulation of Brain Connectivity in Parkinson Disease after Automatic Mechanical Peripheral Stimulation: A Pilot Study 87
Analyzing gait variability and dual-task interference in patients with Parkinson's disease and freezing by means of the word-color Stroop test 86
Modification of respiratory function parameters in patients with severe Parkinson's disease 84
A toxin injection in patients with blepharospasm, torticollis and hemifacial spasm 83
Neuroprotection in Parkinson's disease: clinical trials 82
Robot-assisted gait training versus treadmill training in patients with Parkinson's disease: a kinematic evaluation with gait profile score Epub 2016 82
A novel summary kinematic index for postural characterization in subjects with Parkinson's disease 80
Gastrointestinal dysfunction in Parkinson's disease 80
The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor 80
A pharmacological study of cocaine activity in planaria 80
A double-blind, delayed-start trial of rasagiline in Parkinson’s disease 80
Abnormalities of resting-state functional cortical connectivity in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 80
The coefficient of friction in Parkinson's disease gait 80
Physical activity and neurotrophic factors as potential drivers of neuroplasticity in Parkinson’s disease: a systematic review and meta-analysis 79
Unusual cardiovascular response to intravenous lisuride bolus. Possible drug-induced coronary angiospasm 79
A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet need 79
A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease 78
Abnormalities of cortical neural synchronization mechanisms in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 78
Side-effects of subcutaneous apomorphine in Parkinson's disease 77
Increased expression of dopamine receptors on lymphocytes in Parkinson's disease 75
Case Study 10 74
Continuous apomorphine infusion and neuropsychiatric disorders: a controlled study in patients with advanced Parkinson's disease 74
A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients 74
A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism 74
Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment 74
Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases 74
A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced Dyskinesia 74
A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease 73
Case-control study of multiple system atrophy 73
Adherence to antiparkinson medication in a multicenter European study 73
Urodynamic study in the differential diagnosis between multiple system atrophy and Parkinson's disease 73
Advances in Alzheimer's and Parkinson's Disease: Insights, Progress, and Perspectives 72
Jejunal delivery of levodopa methyl ester 72
A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics 72
A double-blind, delayed-start trial of rasagiline in Parkinson’s disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes 72
White matter disease (Binswanger's encephalopathy) in chronic cerebrovascular disorders 72
Transient atrial fibrillation after subcutaneous apomorphine bolus 72
Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study 72
One year treatment with lisuride delivery pump in Parkinson's disease 71
Transient left bundle branch block following intravenous lisuride bolus 70
Clinical efficacy of a single afternoon dose of effervescent levodopa-carbidopa preparation (CHF 1512) in fluctuating Parkinson disease 70
Comparison of IPX066 with carbidopa-levodopa plus entacapone in advanced PD patients 70
Combination of two different dopamine agonists in the management of Parkinson's disease 69
The Bereitschaftspotential preceding simple foot movement and initiation of gait in Parkinson's disease 69
Clinical Experiences With Levodopa Methylester (Melevodopa) in Patients With Parkinson Disease Experiencing Motor Fluctuations: An Open-Label Observational Study 69
Repeated levodopa infusions in fluctuating Parkinson's disease: clinical and pharmacokinetic data 69
Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term results 69
Correlation between systolic blood pressure variability and global longitudinal strain in patients with Parkinson's disease and dysautonomia 68
Management of gastrointestinal alterations in Parkinson's disease 68
Antagonist effect of terguride in Parkinson's disease 68
Validation of the freezing of gait questionnaire in patients with Parkinson's disease 68
Obstacles to the development of a neuroprotective therapy for Parkinson's disease 68
Determination of apomorphine in human plasma by alumina extraction and high-performance liquid chromatography with electrochemical detection 68
Motor fluctuations in levodopa treatment: clinical pharmacology 68
Effects of robot assisted gait training in progressive supranuclear palsy (PSP): a preliminary report 67
Single-dose studies of a slow-release preparation of levodopa and benserazide (Madopar HBS) in Parkinson's disease 67
GIGYF2 mutations are not frequent cause of familiar Parkinson’s disease 67
The effect of steady-state ropinirole on plasma concentrations of digoxin in patients with Parkinson's disease 67
Use of Apomorphine in Parkinson’s Disease 67
Ropinirole in the treatment of early Parkinson's disease: a 6-month interim report of a 5-year levodopa-controlled study. 056 Study Group 67
Physical activity and neurotrophic factors as potential drivers of neuroplasticity in Parkinson's Disease: A systematic review and meta-analysis 67
Constipation in Parkinson's Disease 66
Non motor symptoms in progressive supranuclear palsy: prevalence and severity 66
The clinical efficacy of oral levodopa methyl ester solution in reversing afternoon "off" periods in Parkinson's disease 66
On-off phenomena in Parkinson's disease. Continuous dopaminergic stimulation 66
The therapeutic concept of continuous dopaminergic stimulation (CDS) in the treatment of Parkinson’s disease 66
The spectrum of "off" in Parkinson's disease: What have we learned over 40 years? 66
Dual dopamine agonist treatment in Parkinson's disease 66
Benefits of treatment with rasagiline for fatigue symptoms in patients with early Parkinson's disease 66
Why delaying levodopa is a good treatment strategy in early Parkinson's disease 66
Parkinson's Disease: Non-motor and non-dopaminergic Features 65
Instrumental diagnosis of multiple system atrophy 65
Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations 65
Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson's disease 65
The Parkinsonian Gait Spatiotemporal Parameters Quantified by a Single Inertial Sensor before and after Automated Mechanical Peripheral Stimulation Treatment 65
Alterations of thermoregulation in Parkinson's disease 65
Clinica Neurologica 65
Managing the critical problems of advanced Parkinson's disease 64
Problems in daily motor performances in Parkinson's disease: the continuous dopaminergic stimulation 64
The clinical efficacy of single morning doses of levodopa methyl ester: dispersible Madopar and Sinemet plus in Parkinson disease 64
trategies for treating patients with advanced Parkinson's disease with disastrous fluctuations and dyskinesias 64
Novel parkin mutations detected in patients with early-onset Parkinson's disease 64
Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson disease 64
A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's disease 64
Abnormal cortical neural synchronization mechanisms in quiet wakefulness are related to motor deficits, cognitive symptoms, and visual hallucinations in Parkinson's disease patients: an electroencephalographic study 63
Malattie Extrapiramidali: aspetti clinici e terapeutici nelle sindromi parkinsoniane 63
Corneal and blink reflexes in Parkinson's disease with "on-off" fluctuations 63
An appraisal of the problem of dementia in Parkinson's disease 63
Wearing-off scales in Parkinson's disease: Critique and recommendations 63
Comparison between L-dopa and lisuride intravenous infusions: a clinical study 63
Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study 63
Totale 7.412
Salva come PNG Salva come JPEG
Categoria #
all - tutte 178.359
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 178.359
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022956 0 0 0 9 6 1 209 281 18 351 6 75
2022/20231.298 561 35 12 118 83 31 2 86 93 113 160 4
2023/20241.031 4 19 81 243 50 45 15 60 13 87 26 388
2024/20252.630 127 591 159 126 95 387 118 185 389 24 90 339
2025/20266.283 499 553 387 263 563 880 1.120 437 456 848 145 132
2026/20272.576 76 814 1.307 379 0 0 0 0 0 0 0 0
Totale 19.753